A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis

被引:21
|
作者
Wu, EQ
Birnbaum, H
Kang, YJ
Parece, A
Mallett, D
Taitel, H
Evans, RJ
机构
[1] Anal Grp Inc, Boston, MA 02199 USA
[2] Ingenix Hlth Intelligence, New Haven, CT USA
[3] Ortho McNeil Pharmaceut Inc, Ortho Womens Hlth & Urol Div, Raritan, NJ USA
[4] Moses Cone Hlth Syst, Greensboro, NC USA
关键词
claims data analysis; incidence; interstitial cystitis; misdiagnosis; prevalence;
D O I
10.1185/030079906X80431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Interstitial cystitis ( IC) is often misdiagnosed as one of several other conditions manifesting similar symptoms. This analysis assesses the potential extent of IC misdiagnosis while considering concomitant conditions in a managed care population and identifies predictors of IC diagnosis. Research design and methods: Administrative insurance claims data covering 1.7 million lives ( 1999 - 2003) were analyzed. Insurance enrollees with >= 1 IC diagnosis ( ICD- 9- CM of 595.1x) were identified as IC patients. A random sample of non- IC controls was selected using a 10: 1 matching ratio. Six- month incidence rates of ` commonly misdiagnosed conditions', ( overactive bladder, urinary tract infection, chronic pelvic pain, endometriosis, prostatitis) were compared before and after patients' initial IC diagnosis and the reduction in incidence rate of commonly misdiagnosed conditions was used as a suggestive measure of the extent of IC misdiagnosis. The Kaplan - Meier method was used to assess the extent that commonly misdiagnosed conditions were predictors of subsequent IC. A Cox Proportional Hazards regression model ( that adjusts for patient demographics, concomitant and misdiagnosed conditions) was used to estimate the hazard ratio ( HR) of these conditions. Similar analyses were performed for the ` commonly concomitant conditions' ( fibromyalgia, irritable bowel syndrome, vulvodynia). Results: There were 992 IC patients and 9920 controls identified. The reduced incidence of commonly misdiagnosed conditions after initial IC diagnosis suggests that the misdiagnosis rate could be as high as 38% within the 6- month period before initial IC diagnosis. Conclusions: Diagnoses of commonly misdiagnosed conditions are significant predictors of future IC diagnosis. When overlooked, potential misdiagnosis of IC can lead to underestimation of the true prevalence of IC. Similarly, diagnoses of commonly concomitant conditions are significant predictors of future IC diagnosis. These initial findings based on claims data suggest hypotheses for further investigation with clinical data. These results suggest more consideration of IC as a diagnosis is warranted, especially when certain diagnoses are repeatedly made and the resulting treatments do not alleviate the patient's symptoms.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 50 条
  • [1] The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis
    Van, QN
    Klose, JR
    Lucas, DA
    Prieto, DA
    Luke, B
    Collins, J
    Burt, SK
    Chmurny, GN
    Issaq, HJ
    Conrads, TP
    Veenstra, TD
    Keay, SK
    [J]. DISEASE MARKERS, 2003, 19 (4-5) : 169 - 183
  • [2] The diagnosis of interstitial cystitis revisited: Lessons learned from the National Institutes of Health Interstitial Cystitis Database Study
    Zermann, DH
    Wunderlich, H
    Schubert, J
    Ishigooka, M
    [J]. JOURNAL OF UROLOGY, 1999, 162 (03): : 807 - 807
  • [3] The diagnosis of interstitial cystitis revisited: Lessons learned from the National Institutes of Health Interstitial Cystitis Database study
    Hanno, PM
    Landis, JR
    Matthews-Cook, Y
    Kusek, J
    Nyberg, L
    [J]. JOURNAL OF UROLOGY, 1999, 161 (02): : 553 - 557
  • [4] Characterizing Health Care Utilization, Direct Costs, and Comorbidities Associated with Interstitial Cystitis: A Retrospective Claims Analysis
    Tung, Amy
    Hepp, Zsolt
    Bansal, Aasthaa
    Devine, Emily Beth
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (04): : 474 - 482
  • [5] CHARACTERIZING HEALTH CARE UTILIZATION, DIRECT COSTS, AND COMORBIDITIES ASSOCIATED WITH INTERSTITIAL CYSTITIS: A RETROSPECTIVE CLAIMS ANALYSIS
    Tung, A.
    Hepp, Z.
    Devine, B.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A130 - A130
  • [6] Immunosuppressant treatment patterns in lupus nephritis: a retrospective US claims database analysis
    Chen, S.
    Wu, N.
    Ting, J.
    Shih, F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S38 - S38
  • [7] DIAGNOSIS OF INTERSTITIAL CYSTITIS
    MASKELL, R
    [J]. JOURNAL OF UROLOGY, 1991, 145 (04): : 839 - 839
  • [8] Diagnosis of interstitial cystitis revisited: Lessons learned from National Institutes of Health Interstitial Cystitis Database Study - Comment
    Wein, AJ
    [J]. JOURNAL OF UROLOGY, 1999, 161 (02): : 557 - 557
  • [9] DIAGNOSIS OF INTERSTITIAL CYSTITIS
    FUGAZZOTTO, P
    [J]. JOURNAL OF UROLOGY, 1993, 150 (01): : 199 - 200
  • [10] THE DIAGNOSIS OF INTERSTITIAL CYSTITIS
    MESSING, EM
    [J]. UROLOGY, 1987, 29 (04) : 4 - 7